Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04495179
Title A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC. (AARDVARC)
Acronym AARDVARC
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Research Site Sacramento California 95817 United States Details
Research Site Tampa Florida 33612 United States Details
Research Site Atlanta Georgia 30318 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site Winston-Salem North Carolina 27157 United States Details
Research Site Brasschaat 2930 Belgium Details
Research Site Gent 9000 Belgium Details
Research Site Bordeaux 33076 France Details
Research Site Villejuif 94805 France Details
Research Site Goyang-si 10408 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Seoul 06591 Korea, Republic of Details
Research Site Barcelona 08041 Spain Details
Research Site Barcelona 8035 Spain Details
Research Site Hospitalet deLlobregat 08907 Spain Details
Research Site Madrid 28034 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field